Maha Othman: How Artificial Intelligence and Machine Learning Can Improve Risk Assessment of Cancer-Associated Thrombosis
Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared Thrombosis and Hemostasis’s a post on LinkedIn:
“Proud of these three brilliant young scientists Adham E., Ali Zidan and Stefania Coroneos for their outstanding work exploring current literature on how artificial intelligence and machine learning can improve risk assessment of cancer-associated thrombosis.
This Seminars in Thrombosis and Hemostasis publication has laid foundation to explore best suited tools, and enabled us to leverage advanced computational approaches to identify patterns that may enhance our ability to predict thrombotic risk, support personalized care, and ultimately improve outcomes for women with cancer.
We are still in the discovery phase and more work is ahead of us!
On this note, I take the opportunity to congratulate George Ilbawi on taking this further and on the recent acceptance of his abstract at IGCS 2026 ‘Enhancing The Feasibility Of Machine Learning For Predicting Cancer-Associated Thrombosis In Small Clinical Cohort Study’.
Thanks to the special support of our data analyst collaborator Sima Afshar Nezhad and of course the contribution of members of my group Yousra Tera Regan Bucciol Adham E. not forgetting the foundational support of our clinican collaborators Queen’s University departments of oncology and gynaecology.”
Seminars in Thrombosis and Hemostasis shared a post on LinkedIn about a recent article by Adham H. El-Sherbini and his colleagues, adding:
“Most Popular Article Award – Free Access
- Machine Learning for Predicting Thrombosis in Cancer Patients
A powerful review highlighting how AI-driven models are transforming hashtag#thrombosis risk prediction in oncology.”
Title: Machine Learning as a Diagnostic and Prognostic Tool for Predicting Thrombosis in Cancer Patients: A Systematic Review
Authors: Adham H. El-Sherbini, Stefania Coroneos, Ali Zidan, Maha Othman

Other posts featuring Maha Othman on Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome